Reduce Human Error on the Drug and Device Manufacturing Floor
Human error causes 80% of drug and device manufacturing failures, studies indicate.
To uncover the secrets of reducing human error, improving your products and fending off the FDA, read on ...
What causes drug and device manufacturing failures and recalls? Human error. Time after time, CAPA investigations single it out as the root cause of violations.
If there were a magic formula for ending human error, we’d share it. But here’s the next best thing — systematic best practices and strategies that have been proven to cut human error and boost success on the factory floor.
Learn them yourself — in a day. No travel required. Gather your colleagues for the best, and most cost effective, training in the industry.
Discover the new management science of human error reduction in drug and device manufacturing.
The conference chairperson is Ginette Collazzo, Ph.D., an authority on industrial/organizational psychology boasting more than 10 years’ experience with major drugmakers, including Bristol-Myers Squibb, J&J, Schering-Plough and Wyeth.
Dr. Collazzo, along with other top professionals, teach you:
- The understanding and use of human error reduction principles within the drug and device manufacturing sector
- How to develop and monitor CAPA plans involving human errors — proven best practices for assuring your CAPA program accomplishes what it’s intended to do
- Case studies that prove the validity of human error reduction principles and how those reductions lead to documented increases in quality improvements, faster times to market and reduced recalls
Key people throughout your company will benefit from this audio CD/Transcript of the virtual conference.
Meet Your Instructors
Dr. Ginette Collazo has spent more than 10 years in technical training, organizational development and human reliability for Bristol-Myers Squibb, Johnson & Johnson, Schering-Plough and Wyeth. An active researcher in specialized studies related to human reliability, she is the author of numerous publications on these topics.
Edith Meléndez is the Director of Parenteral Operations at Bristol-Myers Squibb. She previously was with Schering-Plough for 24 years, focusing on quality manufacturing initiatives.
Stacy Berkshire is a Senior Director of Global Quality Programs at Perrigo. She has recently been focusing on organizational change initiatives, including : developing and leading quality culture change programs and GMP, Right the First Time, Human Error Reduction and other quality training programs.